The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
how to express on their surface uh the the foot that presses on The Brak okay so that's called pdl1 so program death hyphen L1 Lian one which basically reaches across to pd1 on t- cells and tells them shut down basically like mission accomplished don't need to do anything here
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so pd1 we've talked about that's the target of ketrudo but what cancers do it's a nasty little trick is they've figured out how to not all cancers but but the ones that are most responsive um to katruta they have figured out how to express on their surface uh the the foot that presses on the brake okay so that's called pdl1 so program death hyphen L1 ligand one which basically reaches across to pd1 on T cells and tells them shutdown basically like mission accomplished don't need to do anything here
they have figured out how to express on their surface uh the the foot that presses on the brake okay so that's called pdl1